Abstract | PURPOSE: Current methods used to determine pathological examination of the lymphatics after radical cystectomy are tedious and costly. We performed a systemic study of uroplakin II (UP II) and cytokeratin 20 (CK 20) expression in pelvic lymph nodes on multiple sides in patients with bladder cancer. MATERIALS AND METHODS: RESULTS: Of the 19 bladder tumor tissue specimens 19 (100%) and 13 (68.4%) were positive for UP II and CK 20 mRNA expression, respectively. UP II mRNA was detected in 15 of 16 pelvic lymph node samples (93.8%) with pathologically proven metastases, whereas 9 (56.6%) were positive for CK 20 mRNA. The reverse transcriptase-polymerase chain reaction assay for UP II was statistically more sensitive than that for CK 20 in detecting not only primary tumors, but also metastatic pelvic lymph nodes (p = 0.0179 and 0.0373, respectively). Of 66 pelvic lymph node samples without metastasis UP II was detected in 6 (10%), while CK 20 was not. In addition, UP II and CK 20 mRNA could be detected in at least 50 and 500 bladder cancer HT1197 cells, respectively. CONCLUSIONS: These results indicate that UP II might be a more useful marker than CK 20 for detecting micrometastases of bladder cancer in the pelvic lymph nodes, although a greater number of patients and longer followup are needed to come to a definitive conclusion.
|
Authors | Xiuxian Wu, Yoshiyuki Kakehi, Yu Zeng, Rikiya Taoka, Hiroyuki Tsunemori, Mashashi Inui |
Journal | The Journal of urology
(J Urol)
Vol. 174
Issue 6
Pg. 2138-42, discussion 2142-3
(Dec 2005)
ISSN: 0022-5347 [Print] United States |
PMID | 16280744
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- KRT20 protein, human
- Keratin-20
- Membrane Proteins
- RNA, Messenger
- UPK2 protein, human
- Uroplakin II
- Keratins
|
Topics |
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
(metabolism)
- Female
- Humans
- Japan
- Keratin-20
- Keratins
(metabolism)
- Lymph Nodes
(metabolism, pathology)
- Lymphatic Metastasis
(diagnosis)
- Male
- Membrane Proteins
(metabolism)
- Middle Aged
- Neoplasm Staging
- Predictive Value of Tests
- RNA, Messenger
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Sensitivity and Specificity
- Urinary Bladder Neoplasms
(metabolism, pathology)
- Uroplakin II
|